[HTML][HTML] An exosomal miRNA biomarker for the detection of pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) remains a difficult tumor to diagnose and treat.
To date, PDAC lacks routine screening with no markers available for early detection …
To date, PDAC lacks routine screening with no markers available for early detection …
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
A Makler, R Narayanan, W Asghar - Biosensors, 2022 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) remains a difficult tumor to diagnose and treat.
To date, PDAC lacks routine screening with no markers available for early detection …
To date, PDAC lacks routine screening with no markers available for early detection …
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
A Makler, R Narayanan, W Asghar - Biosensors, 2022 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDAC) remains a difficult tumor to diagnose and treat.
To date, PDAC lacks routine screening with no markers available for early detection …
To date, PDAC lacks routine screening with no markers available for early detection …
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
A Makler, R Narayanan, W Asghar - Biosensors, 2022 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) remains a difficult tumor to diagnose and treat.
To date, PDAC lacks routine screening with no markers available for early detection …
To date, PDAC lacks routine screening with no markers available for early detection …
[HTML][HTML] An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
A Makler, R Narayanan, W Asghar - Biosensors, 2022 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDAC) remains a difficult tumor to diagnose and treat.
To date, PDAC lacks routine screening with no markers available for early detection …
To date, PDAC lacks routine screening with no markers available for early detection …
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma.
A Makler, R Narayanan… - Biosensors (2079-6374), 2022 - search.ebscohost.com
Pancreatic ductal adenocarcinoma (PDAC) remains a difficult tumor to diagnose and treat.
To date, PDAC lacks routine screening with no markers available for early detection …
To date, PDAC lacks routine screening with no markers available for early detection …
An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma.
A Makler, R Narayanan, W Asghar - Biosensors, 2022 - europepmc.org
Pancreatic ductal adenocarcinoma (PDAC) remains a difficult tumor to diagnose and treat.
To date, PDAC lacks routine screening with no markers available for early detection …
To date, PDAC lacks routine screening with no markers available for early detection …